ClinConnect ClinConnect Logo
Search / Trial NCT06778629

Transversalis Fascia Plane Block for Laparoscopic Inguinal Hernia Repair

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Jan 12, 2025

Trial Information

Current as of July 02, 2025

Recruiting

Keywords

Transversalis Fascia Plane Block Acute Postoperative Pain Laparoscopic Inguinal Hernia Repair

ClinConnect Summary

This clinical trial is studying a method called the Transversalis Fascia Plane Block (TFPB) to help control pain after laparoscopic inguinal hernia repair surgery. The TFPB involves using ultrasound to guide the injection of a local anesthetic, which can help numb the specific nerves responsible for feeling pain in the area. The researchers want to find out if this technique can make patients feel more comfortable and reduce pain after their surgery.

To be eligible for this trial, participants should be between the ages of 65 and 74 and must be undergoing elective surgery for a unilateral inguinal hernia, meaning they have a hernia on one side of the body. Patients with a history of chronic pain or certain health issues, such as allergies to local anesthetics or a high body mass index, won't be able to take part. Those who join the trial can expect to receive the TFPB injection during their surgery and will be monitored for pain relief afterwards.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • American Society of Anesthesiologists (ASA) classification I- II Patients
  • Unilateral Inguinal Hernia Repair Surgery
  • Elective Operations
  • Exclusion Criteria:
  • Patients with a history of chronic pain
  • Evidence of infection in the intervention area
  • Allergy to local anesthetics
  • Coagulopathy
  • Body-mass index (BMI) ≥ 30
  • Body weight ≤ 50 kg
  • Patients who do not agree to participate in the study

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, Bagcilar, Turkey

Patients applied

0 patients applied

Trial Officials

BAHADIR CIFTCI

Study Chair

ISTANBUL MUH

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported